Arkolith/Insider Trading/ARQT/Form 4

Lin Sue-Jean

DirectorArcutis Biotherapeutics, Inc. (ARQT) · full profile →Form 4 · filed Nov 25, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$778K
Net Open-Market Flow
-$778K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 24, 2025Option exercise(M)18K$8.63$156K45K
Nov 24, 2025Sell(S)25K$30.78$778K27K
Nov 24, 2025Option exercise(M)7K$7.51$54K52K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 24, 2025Option exercise(M)18K—$09K
Nov 24, 2025Option exercise(M)7K—$05K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001867788-25-000005) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML